Cargando…

Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000

In Cameroon, COVID-19 infection spread rapidly and nationwide, with up to 721 deaths reported. To the best of our knowledge, no study reported the on-theground data using a large patients’ dataset to give a comprehensive knowledge on COVID-19 pandemic in Cameroon. The objective of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fokam, Joseph, Takou, Désiré, Nka, Alex Durand, Ka’e, Aude Christelle, Yagai, Bouba, Ambe Chenwi, Collins, Ngoufack Jagni Semengue, Ezechiel, Angong Beloumou, Grâce, Djupsa Ndjeyep, Sandrine Claire, Abba, Aissatou, Pabo, Willy, Gouissi, Davy, Tommo Tchouaket, Michel Carlos, Yatchou, Laeticia, Zam, Krystel, Mama, Lucien, Ekitti, Regine Claudette, Fainguem, Nadine, Kamgaing, Rachel, Sosso, Samuel Martin, Ndembi, Nicaise, Colizzi, Vittorio, Perno, Carlo-Federico, Ndjolo, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202463/ https://www.ncbi.nlm.nih.gov/pubmed/35720804 http://dx.doi.org/10.4081/jphia.2022.2142

Ejemplares similares

High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
por: Fainguem, Nadine Nguendjoung, et al.
Publicado: (2022)

Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2022)

High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness
por: Tchouaket, Michel Carlos Tommo, et al.
Publicado: (2022)

Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé-Cameroon: a cross-sectional and analytical study
por: Fokam, Joseph, et al.
Publicado: (2023)

Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis
por: Tchouaket, Michel Carlos Tommo, et al.
Publicado: (2023)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population
por: SOSSO, SAMUEL MARTIN, et al.
Publicado: (2023)

Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon
por: Abba, Aissatou, et al.
Publicado: (2021)

Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon
por: Sosso, Samuel Martin, et al.
Publicado: (2020)

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2022)

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
por: Fokam, Joseph, et al.
Publicado: (2022)

The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era
por: PABO, WILLY LE ROI TOGNA, et al.
Publicado: (2023)

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon
por: Fokam, Joseph, et al.
Publicado: (2023)

Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
por: Aissatou, Abba, et al.
Publicado: (2023)

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study
por: Togna Pabo, Willy Le roi, et al.
Publicado: (2023)

Challenges faced by the HIV testing system in low- and middle-income countries
por: Kamgaing, Rachel S., et al.
Publicado: (2023)

The 2nd International Conference on Public Health in Africa 12-15 December 2022, Kigali Rwanda
por: Colizzi, Vittorio, et al.
Publicado: (2023)

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients
por: Teto, Georges, et al.
Publicado: (2022)

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
por: Fokam, Joseph, et al.
Publicado: (2023)

Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis
por: Ngoufack Jagni Semengue, Ezechiel, et al.
Publicado: (2022)

Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2021)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2020)

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020)

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
por: Fokam, Joseph, et al.
Publicado: (2019)

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000)
por: Fokam, Joseph, et al.
Publicado: (2022)

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé
por: Nka, Alex Durand, et al.
Publicado: (2019)

Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings
por: Dobseu, Rodolphe, et al.
Publicado: (2020)

European & Developing Countries Clinical Trials Partnership (EDCTP)
por: Olesen, Ole F.
Publicado: (2017)

Abstracts of the Eighth EDCTP Forum, 6–9 November 2016
Publicado: (2017)

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”
por: Fokam, Joseph, et al.
Publicado: (2019)

EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa
por: Miiro, George M, et al.
Publicado: (2013)

Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa
por: Baba, Marycelin Mandu, et al.
Publicado: (2021)

European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership
por: Matee, Mecky I, et al.
Publicado: (2009)

HLA A*32 is associated to HIV acquisition while B*44 and B*53 are associated with protection against HIV acquisition in perinatally exposed infants
por: Mekue, Linda Mouafo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_25ug0n213h8g195d4tfhkoff8s